Provider of a healthcare technology startup that offers a platform for patients to purchase medicines online, providing access to a wide range of products at competitive prices
2019
Mumbai (India)
Series B
Truemeds is a pioneering telehealth and e-pharmacy platform operates within the healthcare and pharmaceutical sector, focusing on providing affordable and accessible medicines to consumers across India.
Direct Sales: The sale of generic and branded medicines, vitamins, supplements, and health devices through its e-pharmacy platform is the main revenue driver.
Subscription-like Services: For chronic patients, Truemeds offers monthly medicine refill reminders and recurring delivery options, increasing customer retention and lifetime value.
Telehealth Services: While doctor consultations are currently offered free to enhance value and trust, these services support medicine sales and may be monetized in the future.
Personal Care and Health Products: Sales of ancillary health and personal care products add to the revenue mix.
Truemeds primarily serves B2C customers, especially chronic patients and senior citizens who are most affected by high medicine costs. The platform also engages with doctors, pharmacists and distributors to ensure supply chain efficiency and product quality.
Truemeds' unique value proposition lies in its ability to reduce healthcare expenses by offering affordable generic alternatives to prescribed medications. The platform empowers consumers to make informed decisions about their medication choices, ensuring significant cost savings—up to 51% on monthly medical bills for chronic patients. Truemeds also provides a seamless online experience, allowing users to upload prescriptions and receive verified substitutes with the help of in-house pharmacists and empanelled doctors.
Market Expansion: Truemeds is expanding its reach across India, including underserved rural areas and plans to triple its fulfillment centers to improve delivery speed and coverage.
Product Diversification: The company is broadening its catalog to include vitamins, supplements, homeopathic medicines and personal care products.
Technology and Data: Continuous investment in its AI-driven recommendation engine and user-friendly platform enhances customer experience and operational efficiency.
Strategic Partnerships: Collaborations with over 150 distributors and leading logistics partners ensure reliable supply and delivery.
Customer Education and Trust: By providing transparent information, free consultations and educational resources, Truemeds builds long-term trust and loyalty.
$93 Million
4
$44 Million, Series C
as of March 6, 2025
$340Million
as of March 7, 2025
3.7
as of March 7, 2025
Info Edge Ventures
and 4 more741
Proactive For Her
-
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
March 6, 2025 | Series C | $44 Million | - | - | - | Accel, WestBridge Capital, Info Edge Ventures, Konark Trust, MMPL Trust |
March 25, 2023 | Series B | $21.3Million | $132.0Million | $29.6Million | - | WestBridge Capital, Info Edge Ventures, Konark Trust, Asha, MMPL Trust |
February 11, 2022 | Series B | $22.0Million | $76.3Million | $6.7Million | - | WestBridge Capital, Info Edge Ventures, Indian Angel Network Fund, Asha, Indian Angel Network, Konark Trust |
March 23, 2021 | Series A | $5.0Million | $14.5Million | $1.4Million | - | Info Edge Ventures, Indian Angel Network, Asha |
May 16, 2020 | Seed | $665.0K | $2.5Million | $353.0K | 5.3x | Info Edge Ventures ,Allana |